Cytokinetics Inc (NAS:CYTK)
$ 48.35 -0.63 (-1.29%) Market Cap: 5.07 Bil Enterprise Value: 5.27 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Cytokinetics Inc at H C Wainwright Global Life Sciences Conference Transcript

Apr 08, 2019 / 08:50AM GMT
Release Date Price: $8.53 (-1.39%)
Unidentified Analyst

Okay, great. I think we will get started on our next presentation. So up next, we have Cytokinetics, who is represented by the CEO Robert Blum, who will give his presentation and overview of the Company.

So with that, I will just turn it over to you.

Robert Blum
Cytokinetics, Incorporated - President and CEO

So thank you for joining us this morning here in London. I understand this is also being webcast, so for those who might be listening in, thank you to H.C. Wainwright for inviting us to participate in this conference.

And over the next 20 minutes I will tell you about a company called Cytokinetics that is over 20 years old now and a pioneer and leader in the area of muscle biology and muscle pharmacology. And we are starting our presentation with a picture of those patients with whom we have relationships.

This represents just the tip of the iceberg for those for whom we dedicate our research and development and who have inspired us over these many years. I will be making forward-looking statements and refer you to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot